Hermine, Olivier

Olivier Hermine MD, PhD is a professor of hematology at the University of Paris Cité, head of the clinical department of hematology and national reference center on mastocytosis at the Hospital Necker Enfants-Malades. He is also head of a research group on physiopathology and treatment of hematological disorders at the Imagine Institute. He is current member of the American Society of Hematology and active member of the Red cell committee. He is a board member of EBMT Lymphoma working group, European Mantle cell network, member of the scientific and administrative committee and coordinator of the Mantle cell group of the LYSA (French Lymphoma study group), and of the international retrovirology association (IRVA; HTLV-1 and related virus including T cell lymphoma) and co-founder and scientific director of the French CELAC group on Intestinal Lymphoma. He is elected member of the French national academy of science. He teaches hematology both basic and clinical at different levels from undergraduate to MD and PhD. He is a board member of Imagine Institute. He is co-author of more than 920 publications in International Scientific Journals. He is co-founder and scientific director of two biotechnologies (Inatherys (monoclonal antibodies) and AB Science (kinase inhibitor). With AB science he pioneered the development of the first kinase inhibitor in mastocytosis in dogs and cats. Overall his research tries to understand and study mechanisms underlying several haematological malignancies and benign hematological disorders in humans and animals, in order to improve care and develop targeted and immune therapies.